{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:36:36Z","timestamp":1770824196628,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T00:00:00Z","timestamp":1191888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:p><jats:bold>Aims:\u2002<\/jats:bold> To compare cyclin D1 and p16<jats:sup>ink4<\/jats:sup> (p16) expression in normal tissue, pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma (CXPA) of the parotid gland.<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> Immunohistochemistry was used to examine cyclin D1 and p16 expression in 43 parotid tumours (29 PAs and 14 CXPAs). Cyclin D1 and p16 were both significantly more likely to be expressed in the neoplastic than in the normal epithelial and stromal components of PA and CXPA (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001 and <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.005, respectively). Cyclin D1 was more likely to be expressed in the malignant components of CXPA than in the benign components of PA (50% versus 31% and 31%, respectively), but the trend was not statistically significant. There was no evidence of this association for p16 (corresponding positivity rates 69% versus 81% and 52%).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our findings provide preliminary evidence of roles for cyclin D1 and p16 in the development of PA and for cyclin D1 in the progression of PA to CXPA.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2007.02853.x","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T09:02:00Z","timestamp":1191920520000},"page":"691-696","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland"],"prefix":"10.1111","volume":"51","author":[{"given":"R S","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Bawdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Fredericks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.25000"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.1100"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100129809"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016487409124645"},{"key":"e_1_2_7_6_2","first-page":"155","volume-title":"Atlas of tumor pathology","author":"Ellis GL","year":"1996"},{"key":"e_1_2_7_7_2","first-page":"1510","article-title":"The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities","volume":"62","author":"Hensen K","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M504334200"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90385-2"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203012"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7809631"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200203000-00013"},{"key":"e_1_2_7_13_2","first-page":"1837","article-title":"Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors","volume":"5","author":"Barbieri F","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_14_2","first-page":"1634","article-title":"Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis","volume":"57","author":"Gansauge S","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_7_15_2","first-page":"975","article-title":"Overexpression of cyclin D1 correlates with recurrence in a group of forty\u2010seven operable squamous cell carcinomas of the head and neck","volume":"55","author":"Michalides R","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2003.08.021"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-419X(98)00017-1"},{"key":"e_1_2_7_18_2","first-page":"2810","article-title":"Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue","volume":"5","author":"Bova RJ","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2004.08.004"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-199808000-00007"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1078\/0344-0338-00435"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.11.049"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.124.1.88"},{"key":"e_1_2_7_24_2","first-page":"1697","article-title":"p16INK4A adenovirus\u2010mediated gene therapy for human head and neck squamous cell cancer","volume":"4","author":"Rocco JW","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02729.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<279::AID-PATH240>3.0.CO;2-C"},{"key":"e_1_2_7_27_2","first-page":"977","article-title":"Overexpression of the cyclin\u2010dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer","volume":"5","author":"Lee CT","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_28_2","first-page":"439","article-title":"D11S287,a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL\u20101","volume":"6","author":"Lammie GA","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1210"},{"key":"e_1_2_7_30_2","first-page":"401","article-title":"Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16\/p14ARF","volume":"21","author":"Lang JC","year":"2002","journal-title":"Int. J. Oncol."}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2007.02853.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2007.02853.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:53:54Z","timestamp":1697187234000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2007.02853.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1365-2559.2007.02853.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02853.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,9]]},"assertion":[{"value":"2007-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}